The Real Cost of Delaying CPAP Therapy

Obstructive Sleep Apnea (OSA) is one of the most common and often underdiagnosed sleep disorders in the United States. It’s estimated that 30 million Americans live with OSA, many without even knowing it. OSA disrupts breathing during sleep which puts serious strain on the body which can lead to developing heart disease, high blood pressure,…

Menopause and Sleep Disorders

Menopause is a significant phase in a woman’s life, marking the end of her reproductive cycle. It is often accompanied by a range of symptoms, both physical and emotional. One of the most common and troubling issues faced by women during menopause is sleep disorders. These disorders can severely impact the quality of life, making…

The FDA Approves the First Prescription Medication for OSA Patients with Obesity 

The FDA has approved the first medication useful in treating adults exhibiting moderate-to-severe OSA with obesity. Eli Lilly and Company announced the US Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. “Too often, OSA is brushed off as…